Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.74M.
ENTERPRISE VALUE (EV)
$2.74M
Lakewood-Amedex Biotherapeutics, Inc.
Market Cap
$1.48M
Enterprise Value (EV)
$2.74M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lakewood-Amedex Biotherapeutics, Inc. (LABT) | $1.48M | $2.74M |
| INVO Fertility, Inc. (IVF)vs › | $1.47M | $1.66M |
| Curis, Inc. (CRIS)vs › | $1.48M | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.44M | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | N/A |
| Genprex, Inc. (GNPX)vs › | $1.32M | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.20M | $9.73M |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | $1.43M |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.12M | $2.15M |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | N/A |
Market Cap
$1.48M
Total Debt
$1.50M
Cash
$236400.00
Enterprise Value
$2.74M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
